Pharma Journalist 9038 posts 0 comments

Takeda Pharmaceutical Company Limited announced that it has entered into an agreement to divest a portfolio of select non-core over-the-counter (OTC) and prescription pharmaceutical…
Read More...

Affinivax, Inc. a clinical stage biotechnology company with its novel MAPS technology platform for vaccines and immunotherapies, announced the completion of a $120 million Series B…
Read More...

Scancell Holdings plc, the developer of novel immunotherapies for the treatment of cancer, announces that it has initiated a research programme to develop a vaccine for COVID-19. The…
Read More...

SMi reports: Registration is now open for the Inaugural Aseptic Processing Conference, which will convene in London on 23rd and 24th September 2020. SMi Group are proud to announce…
Read More...

ProThera Biologics, Inc. and Takeda Pharmaceutical Company Limited announced that they have entered into a global licensing agreement to develop a novel plasma-derived Inter-alpha…
Read More...

Catalent announced the completion of its $14 million expansion to increase the biologics packaging capabilities and capacity at its Bloomington, Indiana facility. The completed…
Read More...

Griffith University researchers have joined forces with scientists from Indian Immunologicals Limited (IIL), a leading vaccines manufacturing company based in Hyderabad, India to…
Read More...

Diamond Pharma Services announced its pharmacovigilance division, Diamond PV Services, has acquired PharmaCentral (https://pharmacentral.ie/), an innovative pharmacovigilance services…
Read More...

Data from the Phase III REACH2 study published today in The New England Journal of Medicine show Jakavi (ruxolitinib) improves outcomes across a range of efficacy measures in patients…
Read More...

Novartis announced that the US Food and Drug Administration (FDA) granted Regenerative Medicine Advanced Therapy (RMAT) designation to Kymriah (tisagenlecleucel), for an investigational…
Read More...